hydroxyproline has been researched along with ubiquinone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giri, SN; Graver, DF | 1 |
Babal, P; Bernatova, I; Gvozdjakova, A; Krajcirovicova, K; Kucharska, J; Luptak, I; Matuskova, J; Pechanova, O; Simko, F; Simko, J; Sumbalova, Z | 1 |
Holmes, RP; Johnson, LC; Jönsson, TJ; Lowther, WT; Parsonage, D; Summitt, CB | 1 |
3 other study(ies) available for hydroxyproline and ubiquinone
Article | Year |
---|---|
Effects and levels of coenzyme Q10 in lung and liver in bleomycin-hamster model of lung fibrosis.
Topics: Animals; Bleomycin; Chromatography, High Pressure Liquid; Cricetinae; Dose-Response Relationship, Drug; Hydroxyproline; Injections, Intraperitoneal; Liver; Lung; Male; Mesocricetus; Organ Size; Pulmonary Fibrosis; Ubiquinone | 1991 |
L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
Topics: Animals; Antihypertensive Agents; Arginine; Brain; Hydroxyproline; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Ubiquinone | 2005 |
Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria.
Topics: Biocatalysis; Catalytic Domain; Enzyme Inhibitors; Flavin-Adenine Dinucleotide; Flavoproteins; Furans; Humans; Hydroxyproline; Hyperoxaluria, Primary; Ligands; Models, Molecular; Mutant Proteins; Peptide Fragments; Proline; Proline Oxidase; Protein Conformation; Recombinant Proteins; Substrate Specificity; Terminology as Topic; Ubiquinone | 2015 |